ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Press Ganey Secures Sixth US Patent for Natural Language Processing

New patent enhances client ability to actionize comments and feedback

Press Ganey last week announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,170,172 expanding the company’s artificial intelligence capabilities to better process and actionize structured and unstructured healthcare experience data. This patent is the sixth in a portfolio that covers key innovations from Press Ganey’s NarrativeDx artificial intelligence platform, specifically built for the language of healthcare.

“Ensuring our clients have information at their fingertips is one of our top priorities, and advancements such as this are an impactful step in our continuous journey to provide the best tools available,” said Dan Litwer, chief client officer, Press Ganey. “By receiving this patent, and continuing to improve upon our artificial intelligence functionalities, our clients can discover more actionable data through more concise patient comments and feedback.”

Press Ganey continues to offer the only platform with the ability to accumulate and analyze large volumes of unstructured datasets across the care continuum, now advanced with additional intelligence to enhance natural language processing and make the machine learning more applicable to more domains, like member experience, safety and quality data. The new patent enhances Press Ganey’s ability to actionize comments and identify associations and correlations within various datasets.

For example, there is a significant difference in saying “my doctor is outstanding” and “my bill is outstanding” when deciphering the data. In each instance, “outstanding” carries extremely different positive and negative connotations depending on the context of the experience. With this breakthrough technology, clients will now be able to understand the nuance of experience across the entire care continuum.

“This patent recognizes our continued innovation in healthcare artificial intelligence. For the first time, healthcare leaders can identify actionable insights across multiple domains such as patient, caregiver and health plan member experience with a single platform,” said Kyle Robertson, vice president, Press Ganey, and inventor on this patent.

To schedule a demo to learn more about Press Ganey’s NarrativeDx technology, visit PressGaney.com.

About Press Ganey

Press Ganey pioneered the health care performance improvement movement 35 years ago. Today Press Ganey offers an integrated suite of solutions that enable enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform built on a foundation of data security, Press Ganey solutions address safety, clinical excellence, patient experience and workforce engagement. The company works with more than 41,000 health care facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality and experience of care.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.